Career Development Programs in Diabetes Research for Endocrinologists (K12 Clinical Trial Optional)
This Funding Opportunity Announcement is intended to foster the development of a diverse and highly trained workforce of endocrinologists to assume leadership roles related to the Nations biomedical and behavioral research efforts in the area of type 1 diabetes (T1D). T1D is an autoimmune disease that occurs in both children and adults. Therefore, the NIDDK will award physician scientist career development program (K12) grants to eligible institutions to provide a program to prepare adult and/or pediatric endocrinologists, selected by the institution, for careers in basic or clinical research related to T1D. This Funding O...
Source: NIDDK Funding Opportunities - February 14, 2018 Category: Endocrinology Source Type: funding
Immune System Engineering For Targeted Tolerance in Type 1 Diabetes (R01 Clinical Trial Not Allowed)
Type 1 diabetes (T1D) results in part from the autoimmune-mediated dysfunction or destruction of insulin-producing pancreatic beta cells. This funding opportunity is for projects that seek to discover ways to change the course of the disease by directly establishing tolerance. Immune responses could be engineered for tolerance induction through the manipulation of antigens, cells, or cellular microenvironments. Collaborations between T1D experts and investigators from other fields, including (but not limited to) cancer immunology and biomaterials engineering, are especially encouraged.Lisa Spain, Ph.D. | RFA-DK-17-020 (Sou...
Source: NIDDK Funding Opportunities - February 14, 2018 Category: Endocrinology Source Type: funding
Career Development Programs in Diabetes Research for Endocrinologists (K12 Clinical Trial Optional)
This Funding Opportunity Announcement is intended to foster the development of a diverse and highly trained workforce of endocrinologists to assume leadership roles related to the Nations biomedical and behavioral research efforts in the area of type 1 diabetes (T1D). T1D is an autoimmune disease that occurs in both children and adults. Therefore, the NIDDK will award physician scientist career development program (K12) grants to eligible institutions to provide a program to prepare adult and/or pediatric endocrinologists, selected by the institution, for careers in basic or clinical research related to T1D. This Funding O...
Source: NIDDK Funding Opportunities - February 14, 2018 Category: Endocrinology Source Type: funding
FY17National Lupus Outreach and Clinical Trial Education Program
Funding Opportunity ID: 289374 Opportunity Number: MP-CPI-17-002 Opportunity Title: FY17National Lupus Outreach and Clinical Trial Education ProgramOpportunity Category: DiscretionaryOpportunity Category Explanation: Funding Instrument Type: GrantCategory of Funding Activity: HealthCategory Explanation: CFDA Number(s): 93.137Eligible Applicants: Others (see text field entitled "Additional Information on Eligibility" for clarification)Additional Information on Eligibility: Eligible Applicants.
State governments
County Governments
Special district governments
Public and State controlled institutions of ...
Source: Grants.gov - February 19, 2017 Category: Research Tags: Health Source Type: funding
FY17National Lupus Outreach and Clinical Trial Education Program
Funding Opportunity ID: 289374 Opportunity Number: MP-CPI-17-002 Opportunity Title: FY17National Lupus Outreach and Clinical Trial Education ProgramOpportunity Category: DiscretionaryOpportunity Category Explanation: Funding Instrument Type: GrantCategory of Funding Activity: HealthCategory Explanation: CFDA Number(s): 93.137Eligible Applicants: Others (see text field entitled "Additional Information on Eligibility" for clarification)Additional Information on Eligibility: Eligible Applicants.
State governments
County Governments
Special district governments
Public and State controlled institutions of ...
Source: Grants.gov - December 31, 2016 Category: Research Tags: Health Source Type: funding
Advanced Biomanufacturing of Therapeutic Cells (ABTC)
Preliminary Proposal Deadline Date: January 4, 2017 Preliminary Proposal Submission Deadline Program Guidelines: NSF 17-502In recent years, somatic cells as therapeutic agents have provided new treatment approaches for a number of pathological conditions that were deemed untreatable, or difficult to treat. Several successful cell therapies using T cells have been demonstrated for cancer and autoimmune diseases, while stem cell therapies have given relief for heart disease and stroke. Hundreds of clinical trials are ongoing to examine efficacy of cell therapies for a variety of other diseases including diabetes, ...More at ...
Source: NSF Upcoming Due Dates - December 5, 2016 Category: Science Source Type: funding
Cooperative Research Agreements Related to the World Trade Center Health Program (U01)
Funding Opportunity Number: RFA-OH-16-008 Opportunity Category: DiscretionaryFunding Instrument Type: Cooperative AgreementCategory of Funding Activity: HealthCFDA Number: 93.262Eligible Applicants State governmentsCounty governmentsCity or township governmentsSpecial district governmentsIndependent school districtsPublic and State controlled institutions of higher educationNative American tribal governments (Federally recognized)Public housing authorities/Indian housing authoritiesNative American tribal organizations (other than Federally recognized tribal governments)Nonprofits having a 501(c)(3) s...
Source: Grants.gov - March 9, 2016 Category: Research Tags: Health Source Type: funding
Cooperative Study Group for Autoimmune Disease Prevention (U01)
Funding Opportunity Number: RFA-AI-16-003 Opportunity Category: DiscretionaryFunding Instrument Type: Cooperative AgreementCategory of Funding Activity: HealthCFDA Number: 93.85593.856Eligible Applicants State governmentsCounty governmentsCity or township governmentsSpecial district governmentsIndependent school districtsPublic and State controlled institutions of higher educationNative American tribal governments (Federally recognized)Public housing authorities/Indian housing authoritiesNative American tribal organizations (other than Federally recognized tribal governments)Nonprofits having a 501(c...
Source: Grants.gov - February 25, 2016 Category: Research Tags: Health Source Type: funding
Cooperative Study Group for Autoimmune Disease Prevention (U01)
Funding Opportunity RFA-AI-16-003 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) solicits applications from institutions or consortia of institutions to participate in a cooperative study group focused on prevention of human autoimmune disease. The ultimate goal of the FOA is to develop the knowledge base necessary to design selective preventive interventions that could be administered efficiently and safely to the general population or to individuals at risk of autoimmune disease, including infants and children. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - February 25, 2016 Category: Research Source Type: funding
Michigan Lupus Epidemiology and Surveillance (MILES) Program Longitudinal Cohort Study
Funding Opportunity Number: RFA-DP-16-002 Opportunity Category: DiscretionaryFunding Instrument Type: Cooperative AgreementCategory of Funding Activity: HealthCFDA Number: 93.283Eligible Applicants Others (see text field entitled "Additional Information on Eligibility" for clarification)Agency Name: HHS-CDC-HHSCDCERAClosing Date: Feb 05, 2016Award Ceiling: $1,000,000Expected Number of Awards: 1Creation Date: Dec 07, 2015Funding Opportunity Description: Lupus is a prototypical autoimmune disease with a wide spectrum of illness that can be limited to the skin or can affect almost any...
Source: Grants.gov - December 8, 2015 Category: Research Tags: Health Source Type: funding
Human Immunology Project Consortium (U19)
Funding Opportunity Number: RFA-AI-15-041 Opportunity Category: DiscretionaryFunding Instrument Type: Cooperative AgreementCategory of Funding Activity: HealthCFDA Number: 93.85593.856Eligible Applicants State governmentsCounty governmentsCity or township governmentsSpecial district governmentsIndependent school districtsPublic and State controlled institutions of higher educationNative American tribal governments (Federally recognized)Public housing authorities/Indian housing authoritiesNative American tribal organizations (other than Federally recognized tribal governments)Nonprofits having a 501(c...
Source: Grants.gov - November 21, 2015 Category: Research Tags: Health Source Type: funding
Human Immunology Project Consortium (U19)
Funding Opportunity RFA-AI-15-041 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) on the Human Immunology Project Consortium (HIPC) solicits applications from single institutions, or consortia of institutions, to participate in a network of human immunology profiling research groups in the area of infectious diseases, including HIV. The purpose of this FOA is to characterize human immune responses/mechanisms elicited by vaccinations, adjuvants or natural infection by capitalizing on recent advances in immune profiling technologies. Studies supported under this FOA will measure...
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 19, 2015 Category: Research Source Type: funding
Developing and Disseminating Programs to Build Sustainable Lupus Awareness, Knowledge, Skills and Partnerships
Funding Opportunity Number: CDC-RFA-DP15-1511 Opportunity Category: DiscretionaryFunding Instrument Type: Cooperative AgreementCategory of Funding Activity: HealthCFDA Number: 93.06893.13593.328Eligible Applicants State governmentsCounty governmentsCity or township governmentsSpecial district governmentsIndependent school districtsPublic and State controlled institutions of higher educationNative American tribal governments (Federally recognized)Public housing authorities/Indian housing authoritiesNative American tribal organizations (other than Federally recognized tribal governments)Nonprofits havi...
Source: Grants.gov - June 12, 2015 Category: Research Tags: Health Source Type: funding
Call for Applications: James T. Lubin Clinician Scientist Fellowship Award
The objective is to provide salary and research support for 2 years of post-doctoral training to ensure a future of well-trained clinician-scientists focused on rare neuro-immune diseases. The total salary requested must be based on a full-time, 12-month staff appointment. Funds may be used to support tuition and fees related to career development, research expenses, such as supplies, equipment and technical personnel and travel to research meetings or training. Indirect Costs (also known as Facilities & Administrative [F&A] Costs) are not reimbursed by The TMA. Eligibility and Additional Guidelines 1. ...
Source: ScanGrants feed - November 19, 2014 Category: Research Authors: Transverse Myelitis Association Source Type: funding
